The finding revealed an association between the PNPLA3 SNP rs2896019 (OR, 3.37; 95% CI, 2.21–5.14) and the development of HCC in patients with metabolic dysfunction–associated steatohepatitis. This evidence concerns the gene PNPLA3 and hepatocellular carcinoma.